Controlled Clinical Trial
Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
Crit. Care Med. 2007 Jul 1;35(7):1685-90.
Randomized Controlled Trial
Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial.
Br J Anaesth. 2005 May 1;94(5):586-91.
Meta Analysis
Recombinant activated factor VII in cardiac surgery: a meta-analysis.
J. Cardiothorac. Vasc. Anesth. 2009 Feb 1;23(1):34-40.